0591-3692 : Paliperidone 1.5 mg Oral Tablet, Film Coated, Extended Release


NDC0591-3692
Labeler: Actavis Pharma, Inc.
Product Type: Human Prescription Drug
Drug Name:  Paliperidone
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: ANDA202645
Rev. Date: 


Appearance:


Markings: WPI;1;5
Shapes:  Round
Colors:  Brown
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0591-3692-10: 1000 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (0591‑3692‑10)
  • 0591-3692-19: 90 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (0591‑3692‑19)
  • 0591-3692-30: 30 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (0591‑3692‑30)

Active Ingredients:

  • Paliperidone

Dosage Strength:

  • 1.5 mg

Inactive Ingredients:

  • Butylated Hydroxytoluene
  • Cellulose Acetate
  • Silicon Dioxide
  • Fd&c Red No. 40
  • Aluminum Oxide
  • Hydroxypropyl Cellulose (Type H)
  • Hypromelloses
  • Ferrosoferric Oxide
  • Polyethylene Glycols
  • Povidones
  • Propylene Glycol
  • Sodium Chloride
  • Stearic Acid
  • Titanium Dioxide
  • Ferric Oxide Yellow
  • Ferric Oxide Red
  • Polyvinyl Alcohol
  • Talc

Pharmaceutical Classes:

  • Atypical Antipsychotic [EPC]

Related Products:

Based on records with the same trade name.
  • 0591-3693 Paliperidone 3 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 0591-3694 Paliperidone 6 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 0591-3695 Paliperidone 9 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 0378-3978 Paliperidone 1.5 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-3979 Paliperidone 3 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-3980 Paliperidone 6 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-3981 Paliperidone 9 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 10147-0951 Paliperidone 1.5 mg Oral Tablet, Extended Release by Patriot Pharmaceuticals, LLC
  • 10147-0952 Paliperidone 3 mg Oral Tablet, Extended Release by Patriot Pharmaceuticals, LLC
  • 10147-0953 Paliperidone 6 mg Oral Tablet, Extended Release by Patriot Pharmaceuticals, LLC
  • 10147-0954 Paliperidone 9 mg Oral Tablet, Extended Release by Patriot Pharmaceuticals, LLC
  • 16714-866 Paliperidone 1.5 mg Oral Tablet, Extended Release by Northstar Rxllc
  • 16714-867 Paliperidone 3 mg Oral Tablet, Extended Release by Northstar Rxllc
  • 16714-868 Paliperidone 6 mg Oral Tablet, Extended Release by Northstar Rxllc
  • 16714-869 Paliperidone 9 mg Oral Tablet, Extended Release by Northstar Rxllc
  • 42292-026 Paliperidone 3 mg Oral Tablet, Film Coated, Extended Release by Mylan Institutional Inc.
  • 42292-027 Paliperidone 6 mg Oral Tablet, Film Coated, Extended Release by Mylan Institutional Inc.
  • 47335-744 Paliperidone 1.5 mg Oral Tablet, Extended Release by Sun Pharma Global Fze
  • 47335-765 Paliperidone 3 mg Oral Tablet, Extended Release by Sun Pharma Global Fze
  • 47335-766 Paliperidone 6 mg Oral Tablet, Extended Release by Sun Pharma Global Fze
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0591-3692 QR Code

< Prev: 0591-3686Next: 0591-3693 >

Related Discussions:

Paliperidone Palmitate
Does IM injection Paliperidone Palmitate (Invega Sustenna) lose potency or become unsafe if it has been stored in far ab... 2 replies




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 January 2017.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA